Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2022 Mar 18;15(4):e008528. doi: 10.1161/CIRCOUTCOMES.121.008528

Table 2.

Clinical status of surviving participants following acute myocardial infarction, northern Tanzania, 2019

Participants surviving to 3 months (N=77) Participants surviving to 6 months (N=70) Participants surviving to 9 months (N=66) Participants surviving to 12 months (N=59)
Symptoms
Persistent anginal symptoms 62 (80.5%) 55 (78.6%) 57 (86.4%) 43 (72.9%)
Severity of anginal symptoms
 CCS* class I 25 (32.5%) 20 (28.6%) 13 (19.7%) 14 (23.7%)
 CCS* class II 8 (10.4%) 17 (24.3%) 17 (25.8%) 5 (8.5%)
 CCS* class III 19 (24.7%) 9 (12.9%) 16 (24.2%) 11 (18.6%)
 CCS* class IV 10 (13.0%) 9 (12.9%) 11 (16.7%) 13 (22.0%)
Heart failure symptoms 26 (33.8%) 18 (25.7%) 21 (31.8%) 15 (25.4%)
Medications
Taking aspirin or other antiplatelet 6 (7.8%) 2 (2.9%) 4 (6.1%) 5 (8.5%)
Taking any antihypertensive 10 (13.0%) 7 (10.0%) 6 (9.1%) 8 (13.6%)
Taking any statin 2 (2.6%) 2 (2.9%) 1 (1.5%) 1 (1.7%)
Health behaviors
Currently using tobacco 3 (3.9%) 0 (0%) 1 (1.5%) 0 (0%)
Exercising regularly 47 (61.0%) 46 (65.7%) 44 (66.7%) 38 (64.4%)
Limiting salt intake 70 (90.9%) 64 (91.4%) 63 (95.5%) 53 (89.8%)
Limiting fatty foods 68 (88.3%) 60 (77.9%) 57 (86.4%) 52 (88.1%)
Health literacy
Feels they understand their diagnosis 43 (55.8%) 45 (64.3%) 48 (72.7%) 46 (78.0%)
Feels they understand their treatment 66 (85.7%) 61 (87.1%) 53 (80.3%) 53 (89.8%)
Healthcare
Received follow-up appointment in preceding 3 months 62 (80.5%) 41 (58.6%) 34 (51.5%) 28 (47.5%)
Ever re-hospitalized (cumulative) 26 (33.8%) 28 (40.0%) 29 (43.9%) 30 (50.8%)
Ever undergone cardiac catherization (cumulative) 5 (6.5%) 6 (8.6%) 6 (9.1%) 7 (11.9%)
*

CCS: Canadian cardiovascular society25